Experimental Thrombosis and Antiphospholipid Antibodies: New Insights
- 30 September 2000
- journal article
- review article
- Published by Elsevier BV in Journal of Autoimmunity
- Vol. 15 (2), 241-247
- https://doi.org/10.1006/jaut.2000.0420
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Do leukocytes contribute to impaired microvascular tissue perfusion after arterial repair?Microsurgery, 1998
- Thrombogenic properties of antiphospholipid antibodies do not depend on their binding to β2 glycoprotein 1 (β2GP1) aloneLupus, 1998
- Endothelial cells as target for antiphospholipid antibodies. Human Polyclonal and Monoclonal Anti‐β2‐Glycoprotein I Antibodies React In Vitro with Endothelial Cells Through Adherent β2‐Glycoprotein I and Induce Endothelial ActivationArthritis & Rheumatism, 1997
- Clinical uses of intravenous immunoglobulin in pregnancyAmerican Journal of Obstetrics and Gynecology, 1997
- Hypercoagulable State in Patients With Antiphospholipid Syndrome Is Related to High Induced Tissue Factor Expression on Monocytes and to Low Free Protein SArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Activation of cultured vascular endothelial cells by antiphospholipid antibodies.JCI Insight, 1995
- Antiendothelial Cell Antibodies in Patients with the Antiphospholipid SyndromeAutoimmunity, 1991
- Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodiesBritish Journal of Haematology, 1990
- Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes.Annals Of The Rheumatic Diseases, 1988
- SYNDROME OF THE BLACK SWANRheumatology, 1987